论文部分内容阅读
美国学者Wiviott等研究发现,在经皮冠状动脉介入治疗(PCI)的患者中,无论负荷和维持剂量的Prasugrel,血小板聚集抑制水平(IPA)均优于大剂量的氯比格雷。大量研究表明,阿司匹林与噻吩并吡啶类药物的联合应用,是急性冠状动脉综合征和PCI患者预防缺血事件发生的重要
American scholar Wiviott et al found that in patients undergoing percutaneous coronary intervention (PCI), platelet aggregation inhibition (IPA) was superior to high-dose clopidogrel in both loading and maintenance doses of Prasugrel. Numerous studies have shown that the combination of aspirin and thienopyridine drugs is important in the prevention of ischemic events in patients with acute coronary syndrome and PCI